The Analysis of Multinational Cost-Effectiveness Data for Reimbursement Decisions: A Critical Appraisal of Recent Methodological Developments

Author： Manca Andrea Sculpher Mark J. Goeree Ron

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.28, Iss.12, 2010-12, pp. : 1079-1096

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

`Lost in Translation': Accounting for Between-Country Differences in the Analysis of Multinational Cost-Effectiveness Data

By Manca Andrea Willan Andrew R.

PharmacoEconomics, Vol. 24, Iss. 11, 2006-01 ,pp. : 1101-1119

Adis International

Access to resources Recommend Favorite

Cost-Effectiveness Analysis and the Consistency of Decision Making: Evidence from Pharmaceutical Reimbursement in Australia (1991 to 1996)

By George B.

PharmacoEconomics, Vol. 19, Iss. 11, 2001-11 ,pp. : 1103-1109

Adis International

Access to resources Recommend Favorite

How Do Cost-Effectiveness Analyses Inform Reimbursement Decisions for Oncology Medicines in Canada? The Example of Sunitinib for First-Line Treatment of Metastatic Renal Cell Carcinoma

By Chabot Isabelle Rocchi Angela

Value in Health, Vol. 13, Iss. 6, 2010-09 ,pp. : 837-845

Blackwell Publishing

Access to resources Recommend Favorite

Cost–effectiveness analysis in pharmacogenomics

By Payne Katherine Shabaruddin Fatiha H

Pharmacogenomics, Vol. 11, Iss. 5, 2010-05 ,pp. : 643-646

Future Medicine

Access to resources Recommend Favorite

A Review of: "Statistical Analysis of Cost-Effectiveness Data, by A. R. Willan and A. H. Briggs"

By Cook John

Journal of Biopharmaceutical Statistics, Vol. 17, Iss. 6, 2007-11 ,pp. : 1243-1245

Taylor & Francis Ltd

Access to resources Recommend Favorite